![{{press_release.company_name}} header image](https://res.cloudinary.com/dmgi9movl/image/upload/dpr_auto,w_auto/v1719420124/press_release/assets/header_images/RCP_Brandsymbol_header_hyzwlf.png)
Rapid Commercialization Partners (RCP), a leader in biotech commercialization strategy and execution, is partnering with Brandsymbol, a premier branding agency that specializes in pharmaceutical and biotech naming, to empower biotech companies as they develop and grow powerful global brands through the combination of commercialization expertise and best-in-class naming.
RCP guides biotechs through the intricate journey from clinical trials to commercialization. Establishing a compelling, globally recognized brand identity, including a trademarkable name, is an important part of a successful commercial launch. Brandsymbol has a proven track record of success crafting thousands of names that resonate internationally, comply with regulations and secure trademarks.
“The complexity and importance of establishing a brand name for a new asset is often underestimated,” said Christina Ansted, RCP co-founder and CEO. “By partnering with Brandsymbol, we can further support clients in early development to address an important milestone — the product name — that impacts commercial timelines.”
As part of the name development process, companies must have brand names approved by government regulatory agencies like the FDA and EMA, and also ensure the name is non-proprietary.
“On the development and commercialization journey for new assets, the importance of timing for name development is often overlooked, said Clayton Tolley, founder, president and CEO of Brandsymbol. “Partnering with RCP allows us to provide integrated support across strategy, branding and commercialization, to set emerging assets up for success.”
Through this partnership, RCP’s clients will have access to a range of services, including brand naming, name safety testing and regulatory submission, corporate naming and market research. This will enable the clients to create a unique and impactful brand identity for their emerging assets, helping them stand out in a crowded market and reach their target audience effectively.
The formidable combination of RCP’s commercialization expertise and Brandsymbol’s naming prowess will help biotech companies establish strategically positioned brands that resonate globally.
About Rapid Commercialization Partners (RCP):
RCP provides the multidisciplinary, executive-level expertise, processes and partnerships that clinical-stage biotech companies need to maximize revenue through efficient, effective commercialization. With a relentless focus on integrated end-to-end strategic commercialization planning and disciplined execution on strategy, RCP positions biotech companies for commercial success by building a foundation for long-term growth. Visit rcpbio.com for more information.
About Brandsymbol:
Brandsymbol is a specialized naming agency that navigates the complexities of global name development in the pharmaceutical and biotech space. Whether creating a world-class brand name, generic (INN/USAN) name, or clinical trial name, their data-driven approach ensures clear, memorable names that secure trademark and regulatory approval and drive commercial success. Visit brandsymbol.com for more information.